Indian pharmaceutical company Alkem MedTech plans to acquire a majority stake in Swiss medtech company Occlutech. Alkem intends to buy up to 55% of Occlutech for EUR 99.4 million, subject to statutory ...

Founded in 2020, medtech company Spirecut develops ultrasound-guided, incision-free surgical technologies for the treatment of soft-tissue conditions of the hand. Its single-use S ...

MSCI Inc. is enhancing its index calculation capabilities in alternative and multi-asset classes, including commodities and cryptocurrencies, through the acquisition of index services provider, and ...

Since the beginning of 2025, Swiss start-ups have been able to apply for funding under the EIC Accelerator Programme again after a four-year hiatus. Neutrality, Verity, Pregnolia and DePoly have now ...

Under the terms of the agreement, Helsinn will provide InVirtuoLabs with access to a proprietary library of structurally diverse compounds, including validated hits with confirmed ...

The number of start-up liquidations increased for the third consecutive year in 2025: the main drivers of this development were a higher number of liquidated late stage start-ups and consolidation ...

Schlieren-based Polaroid Therapeutics has received CE marking for its first product, POLTX_Fiber, a Class IIb antimicrobial gelling fiber dressing. The company is preparing to introduce the wound ...

IMPLANZ expands its founding team, while TECregen has named a new CEO and Vivent Biosignal adds a new CEO to its leadership ...

On International Women’s Day, HeroSupport announced that its first medical device, VENUS SHELL, has received CE Mark certification and is now authorised for marketing across the European Union and ...

The financing will enable Geneva-based Clee Medical to accelerate the development and clinical validation of its Neuro Access ...

Kickfund, a Swiss venture capital firm focused on early-stage deep tech, has crossed the 100-company mark – a milestone it reached in under two years, with a current team of three people. The Swiss ...

When it comes to invested capital, biotech clearly stands out. In 2025, CHF 183.62 million went into female-led biotech startups – half of what they attracted in total that year. This figure has been ...